Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies

Russell Nichols,Erin Doty,Sara Sacco,Dustin D. Ruff,Eric Pearlman,Sheena K. Aurora

Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐Controlled Studies

2019

Russell Nichols
Erin Doty
Sara Sacco
Dustin D. Ruff
Eric Pearlman
Sheena K. Aurora

Objective To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement.

Keywords:

Anesthesia
Placebo
Migraine
Chronic Migraine
Medicine
Dosing
controlled studies
in patient
Pediatrics
Post-hoc analysis
Pharmacotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations